Skip to content

Tert-butyl 4-[2-(azepan-1-yl)-4-(cyclopropanecarbonylamino)benzoyl]piperazine-1-carboxylate

C26H38N4O4 — CID 157036231

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACtert-butyl 4-[2-(azepan-1-yl)-4-(cyclopropanecarbonylamino)benzoyl]piperazine-1-carboxylate
SMILESCC(C)(C)OC(=O)N1CCN(C(=O)c2ccc(NC(=O)C3CC3)cc2N2CCCCCC2)CC1
InChIInChI=1S/C26H38N4O4/c1-26(2,3)34-25(33)30-16-14-29(15-17-30)24(32)21-11-10-20(27-23(31)19-8-9-19)18-22(21)28-12-6-4-5-7-13-28/h10-11,18-19H,4-9,12-17H2,1-3H3,(H,27,31)
InChIKeyUSHKCJMFMHRFGL-UHFFFAOYSA-N
MW470.61 g/mol
LogP4.11
Rot. Bonds4

About Tert-butyl 4-[2-(azepan-1-yl)-4-(cyclopropanecarbonylamino)benzoyl]piperazine-1-carboxylate

Tert-butyl 4-[2-(azepan-1-yl)-4-(cyclopropanecarbonylamino)benzoyl]piperazine-1-carboxylate (PubChem CID 157036231) has the molecular formula C26H38N4O4 and a molecular weight of 470.61 g/mol. Its IUPAC name is tert-butyl 4-[2-(azepan-1-yl)-4-(cyclopropanecarbonylamino)benzoyl]piperazine-1-carboxylate.

Molecular Properties

Compound NameTert-butyl 4-[2-(azepan-1-yl)-4-(cyclopropanecarbonylamino)benzoyl]piperazine-1-carboxylate
PubChem CID157036231
Molecular FormulaC26H38N4O4
Molecular Weight470.61 g/mol
Exact Mass470.29
IUPAC Nametert-butyl 4-[2-(azepan-1-yl)-4-(cyclopropanecarbonylamino)benzoyl]piperazine-1-carboxylate
SMILESCC(C)(C)OC(=O)N1CCN(C(=O)c2ccc(NC(=O)C3CC3)cc2N2CCCCCC2)CC1
InChIInChI=1S/C26H38N4O4/c1-26(2,3)34-25(33)30-16-14-29(15-17-30)24(32)21-11-10-20(27-23(31)19-8-9-19)18-22(21)28-12-6-4-5-7-13-28/h10-11,18-19H,4-9,12-17H2,1-3H3,(H,27,31)
InChIKeyUSHKCJMFMHRFGL-UHFFFAOYSA-N
XLogP4.11
TPSA82.19 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms34
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500470.61
LogP ≤ 54.11
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Analyze Tert-butyl 4-[2-(azepan-1-yl)-4-(cyclopropanecarbonylamino)benzoyl]piperazine-1-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Tert-butyl 4-[2-(azepan-1-yl)-4-(cyclopropanecarbonylamino)benzoyl]piperazine-1-carboxylate?
The IUPAC name of Tert-butyl 4-[2-(azepan-1-yl)-4-(cyclopropanecarbonylamino)benzoyl]piperazine-1-carboxylate (CID 157036231) is tert-butyl 4-[2-(azepan-1-yl)-4-(cyclopropanecarbonylamino)benzoyl]piperazine-1-carboxylate.
What is the SMILES notation for Tert-butyl 4-[2-(azepan-1-yl)-4-(cyclopropanecarbonylamino)benzoyl]piperazine-1-carboxylate?
The canonical SMILES for Tert-butyl 4-[2-(azepan-1-yl)-4-(cyclopropanecarbonylamino)benzoyl]piperazine-1-carboxylate is CC(C)(C)OC(=O)N1CCN(C(=O)c2ccc(NC(=O)C3CC3)cc2N2CCCCCC2)CC1.
What is the InChIKey of Tert-butyl 4-[2-(azepan-1-yl)-4-(cyclopropanecarbonylamino)benzoyl]piperazine-1-carboxylate?
The InChIKey is USHKCJMFMHRFGL-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H38N4O4/c1-26(2,3)34-25(33)30-16-14-29(15-17-30)24(32)21-11-10-20(27-23(31)19-8-9-19)18-22(21)28-12-6-4-5-7-13-28/h10-11,18-19H,4-9,12-17H2,1-3H3,(H,27,31).
What are the key properties of Tert-butyl 4-[2-(azepan-1-yl)-4-(cyclopropanecarbonylamino)benzoyl]piperazine-1-carboxylate?
Tert-butyl 4-[2-(azepan-1-yl)-4-(cyclopropanecarbonylamino)benzoyl]piperazine-1-carboxylate has a molecular weight of 470.61 g/mol, XLogP of 4.11, 4 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for Tert-butyl 4-[2-(azepan-1-yl)-4-(cyclopropanecarbonylamino)benzoyl]piperazine-1-carboxylate is sourced from PubChem (CID 157036231), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.